Cancer clinical trials – Survey evaluating patient participation and acceptance in a university-based Comprehensive Cancer Center (CCC)

Clinical and Translational Radiation Oncology - Tập 13 - Trang 44-49 - 2018
Kerstin A. Kessel1,2,3, Marco M.E. Vogel1,3, Carmen Kessel1,4,3, Henning Bier3,5, Tilo Biedermann3,6, Helmut Friess3,7, Peter Herschbach3,8, Rüdiger von Eisenhart-Rothe3,9, Bernhard Meyer3,10, Marion Kiechle3,11, Ulrich Keller3,12, Christian Peschel3,12, Florian Bassermann3,12, Roland Schmid3,13, Markus Schwaiger3,14, Stephanie E. Combs1,2,4,3
1Department of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany
2Institute for Innovative Radiotherapy (iRT), Helmholtz Zentrum München, Ingolstädter Landstraße 1, Neuherberg, Germany
3Deutsches Konsortium für Translationale Krebsforschung (DKTK), DKTK Partner Site Munich, Germany
4Onkologisches Zentrum im RHCCC am Klinikum rechts der Isar, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany
5Department of Otorhinolaryngology, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany
6Department of Dermatology and Allergy Biederstein, Technical University of Munich (TUM), Biedersteiner Straße 29, Munich, Germany
7Department of Surgery, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany
8Roman Herzog Comprehensive Cancer Center (RHCCC), Department of Psychosomatic Medicine and Psychotherapy, Technical University of Munich (TUM), Trogerstraße 26, Munich, Germany
9Department of Orthopedic Surgery, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany
10Department of Neurosurgery, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany
11Department of Gynecology and Obstetrics, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.
123rd Department of Internal Medicine (Hematology and Oncology), Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany
13Department of Gastroentereology, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany
14Department of Nuclear Medicine, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany

Tài liệu tham khảo

Baron, 2012, Evolution of clinical research: a history before and beyond James Lind, Perspect Clin Res, 3, 149, 10.4103/2229-3485.103599 Al-Almaie, 2003, Evidence based medicine: an overview, J Family Community Med, 10, 17, 10.4103/2230-8229.97841 Blanch, 2008, Predictors of refusal during a multi-step recruitment process for a randomized controlled trial of arthritis education, Patient Educ Couns, 73, 280, 10.1016/j.pec.2008.06.017 Murthy, 2004, Participation in cancer clinical trials: race-, sex-, and age-based disparities, JAMA, 291, 2720, 10.1001/jama.291.22.2720 Mopuru, 2017, Factors influencing participation of psychiatry inpatients in clinical trials, Asian J Psychiatr, 32, 40, 10.1016/j.ajp.2017.11.021 Campbell, 2007, Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study, Health Technol Assess, 11, 10.3310/hta11480 Mills, 2006, Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors, Lancet Oncol, 7, 141, 10.1016/S1470-2045(06)70576-9 Castro, 2016, Patient empowerment, patient participation and patient-centeredness in hospital care: a concept analysis based on a literature review, Patient Educ Couns, 99, 1923, 10.1016/j.pec.2016.07.026 Straube, 2017, Which obstacles prevent us from recruiting into clinical trials: a survey about the environment for clinical studies at a German University Hospital in a Comprehensive Cancer Center, Front Oncol Frontiers, 7, 181, 10.3389/fonc.2017.00181 Khan, 2006, Modeling clinical trials workflow in community practice settings, AMIA Annu Symp Proc. American Medical Informatics Association, 419 DKG Krebsgesellschaft. Zertifizierung onkologischer Zentren, Erhebungsböge, Kennzahlen und Checklisten [Internet]. Available from: https://www.krebsgesellschaft.de/zertdokumente.html archived at http://www.webcitation.org/6wMninfR9. Taylor-Gjevre, 2017, Addressing rural and remote access disparities for patients with inflammatory arthritis through video-conferencing and innovative inter-professional care models, Musculoskeletal Care, 7, 10 Mathew, 2017, A prospective study of telephonic contact and subsequent physical follow-up of radically treated lung cancer patients, Indian J Cancer, 54, 241, 10.4103/0019-509X.219599 Vogel, 2017, mHealth and application technology supporting clinical trials: today's limitations and future perspective of smartRCTs, Front Oncol, 7, 37, 10.3389/fonc.2017.00037 Reider-Demer, 2017, Prospective and retrospective study of videoconference telemedicine follow-up after elective neurosurgery: results of a pilot program, Neurosurg Rev. Springer, Berlin Heidelberg, 27, 24 Wallwiener, 2017, Implementation and feasibility of Electronic Patient-Reported Outcome (ePRO) data entry in the PRAEGNANT real-time advanced and metastatic breast cancer registry, Geburtsh Frauenheilk, 77, 870, 10.1055/s-0043-116223 Moon Y, McGinnis RS, Seagers K, Motl RW, Sheth N, Wright JA, et al. Monitoring gait in multiple sclerosis with novel wearable motion sensors. Thomas FP, editor. PLoS One. 2017;12:e0171346. Chilton, 2018, Ambivalence: a key to clinical trial participation?, Front Oncol, 8, 300, 10.3389/fonc.2018.00300 Oude Rengerink, 2017, Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences, J Clin Epidemiol, 89, 173, 10.1016/j.jclinepi.2016.12.021 Kiernan, 2018, Effects of a methodological infographic on research participants' knowledge, transparency, and trust, Health Psychol, 37, 782, 10.1037/hea0000631 Cowie, 2018, The use of facebook advertising to recruit healthy elderly people for a clinical trial: baseline metrics, JMIR Res Protocols, 7, 10.2196/resprot.7918